SCHEMBL37536

SCHEMBL37536

O=C(O)c1cc2nc(Cc3ccc(Br)s3)[nH]c(=O)c2s1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.60
PARP1 P09874 1/20 0.38
RAB9A P51151 3/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
DAO P14920 1/20 0.37
CDC7 O00311 5/20 0.36
ROCK1 Q13464 5/20 0.36
DBF4 Q9UBU7 5/20 0.36
CCNE1 P24864 4/20 0.36
CDK2 P24941 4/20 0.36
RNASEH1 O60930 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.35
RECQL P46063 1/20 0.34
PIK3R1 P27986 1/20 0.34
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38005 0.83 PDE5A (0.69) PDE5AKDM4ECDC7ROCK1DBF4
SCHEMBL38116 0.81 PDE5A (0.63) PDE5APARP1RAB9AKDM4ESMN1; SMN2
SCHEMBL37513 0.81 PDE5A (0.79) PDE5AKDM4EDAOCDC7ROCK1
SCHEMBL38178 0.80 PDE5A (0.77) PDE5APARP1RAB9AKDM4ESMN1; SMN2
SCHEMBL12505649 0.78 PDE5A (0.65) PDE5ARAB9AKDM4ESMN1; SMN2LMNA
SCHEMBL37942 0.78 PDE5A (0.78) PDE5ARAB9AKDM4ESMN1; SMN2LMNA
SCHEMBL44227 0.78 PDE5A (0.67) PDE5ARAB9ALMNACDC7ROCK1
SCHEMBL37981 0.77 PDE5A (0.66) PDE5ARAB9AKDM4ESMN1; SMN2LMNA
SCHEMBL37583 0.76 PDE5A (0.78) PDE5AKDM4ECDC7ROCK1DBF4
SCHEMBL37737 0.76 PDE5A (0.68) PDE5ARAB9AKDM4ESMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012004900-A1 THIENOPYRIMIDINE COMPOUNDS ASKA PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 WO disclosed